Lupin Receives Approval for Meloxicam Capsules

▴ Lupin Receives Approval for Meloxicam Capsules
Lupin's Meloxicam capsules are a generic equivalent of Vivlodex Capsules of Zyla Life Sciences US.

Pharma major Lupin Limited (Lupin) announced that it has received approval for its Meloxicam Capsules, 5 mg and 10 mg, from the United States Food and Drug Administration (U.S. FDA), to market a generic equivalent of Vivlodex® Capsules, 5 mg and 10 mg, of Zyla Life Sciences US, Inc. The product would be manufactured at Lupin’s Aurangabad facility, India, and is expected to be launched shortly.

Meloxicam Capsules, 5 mg and 10 mg, are indicated for management of osteoarthritis (OA) pain.

Meloxicam Capsules (Vivlodex®) had an annual sales of approximately USD 14 million in the U.S.

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The Company develops and commercializes a wide range of branded and generic formulations, biotechnology products and APIs in over 100 markets in the U.S., India, South Africa and across Asia Pacific , Latin America, Europe and Middle-East regions.

The Company enjoys leadership position in the cardiovascular, anti-diabetic, and respiratory segments and has significant presence in the anti-infective, gastro-intestinal (GI), central nervous system (CNS) and women’s health areas. Lupin is the third largest pharmaceutical company in the U.S. by prescriptions and in India by global revenues. The Company invests 9.6 % of its revenues on research and development.

Lupin has fifteen manufacturing sites, seven research centers, more than 20,000 professionals working globally, and has been consistently recognized as a ‘Great Place to Work’ in the Biotechnology & Pharmaceuticals sector.

Tags : #Lupin #Meloxicam #USFDA

About the Author


Stuti

Btech. Computer Science
MBA aspirant
Preparing for GMAT currently
Interests: AI, writing and books
You can write to me at [email protected]

Related Stories

Loading Please wait...
-Advertisements-


Trending Now

Global Coronavirus deaths cross 1 Million markSeptember 28, 2020
Global Coronavirus deaths cross 1 Million markSeptember 28, 2020
Navigation system and Robotics amongst the new trends in spine surgery says Dr. G Amrit, Orthopedic Spine Surgeon  September 28, 2020
WISI Meetings: Sports Management (India)September 28, 2020
Indoco Remedies launches FEVINDO : 400 mg FavipiravirSeptember 28, 2020
Myanmar extends COVID-19 lockdown in 11 new areas ; International flights suspended till Oct 31September 28, 2020
Nagaland, Manipur Covid-19 News Update Sep 28, 2020September 28, 2020
Delhi reports 3,292 fresh cases of COVID-19 , Himachal Pradesh 195September 28, 2020
9543 people test positive for new Covid-19 cases in KarnatakaSeptember 28, 2020
Zymo Research granted CE IVD Mark for sample collection devicesSeptember 28, 2020
India COVID-19 News update Date across States and UT's - September 27 , 2020September 27, 2020
VAXART investigation initiated by former Louisiana Attorney GeneralSeptember 26, 2020
Bangladesh prepares for ‘second wave’ as Corona death crosses 5,000 markSeptember 26, 2020
Thane district in Maharashtra recorded 1,671 new cases of COVID-19September 26, 2020
NPPA decides to cap price of liquid medical oxygen & medical oxygen cylindersSeptember 26, 2020
Mesothelioma September 26, 2020
Highly effective antibodies identified, may lead to passive COVID-19 vaccineSeptember 26, 2020
Europe has a lot of work to do to prevent COVID-19 transmission: WHOSeptember 26, 2020
Some severe COVID-19 cases linked to genetic mutationsSeptember 26, 2020
Two million Coronavirus deaths : WHO September 26, 2020